Dachaigh › Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil › Utah › Salt Lake City
Sgrùdaidhean clionaigeach Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann an Salt Lake City, UT
Tha aon sgrùdadh airson Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil a’ lorg phàirtichean aig làrach ann no faisg air Salt Lake City. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
A’ fastadhÌre 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- Farmington Health Center, Farmington · 15 mìle air falbh
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A’ fastadhÌre 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A’ fastadhÌre 3
- Huntsman Cancer Institute, Salt Lake City
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
A’ fastadhÌre 1/2
- University of Utah Huntsman Cancer Institute, Salt Lake City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
A’ fastadhÌre 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A’ fastadhSgrùdadh amharc
- Utah Cancer Specialists, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
A’ fastadhÌre 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Utah Cancer Specialists, Salt Lake City
- University of Utah Health Huntsman Cancer Hospital, Salt Lake City
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
A’ fastadhÌre 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
Sgrùdaidhean Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann am bailtean eile
- Houston, TX47 sgrùdaidhean
- Los Angeles, CA42 sgrùdaidhean
- Boston, MA40 sgrùdaidhean
- New York City, NY39 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- St. Louis, MO28 sgrùdaidhean
- Arlington, VA26 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Chicago, IL26 sgrùdaidhean
- Atlanta, GA24 sgrùdaidhean
- San Antonio, TX22 sgrùdaidhean
- New Haven, CT22 sgrùdaidhean
Sgrùdaidhean eile ann an Salt Lake City
- Aillse Sgamhain Neo-chealla-beag31 sgrùdaidhean
- Aillse (gach seòrsa)27 sgrùdaidhean
- Aillse a' bhroilleach27 sgrùdaidhean
- Aillse colorectal22 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Melanoma21 sgrùdaidhean
- Myeloma iomaill21 sgrùdaidhean
- Ailse metastatach20 sgrùdaidhean
- Cancer Ovarian19 sgrùdaidhean
- Obesity18 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Fàilligeadh a' Chridhe17 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.